Phenytoin Sodium Injection
Product Images NDC 51662-1251

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Phenytoin Sodium (NDC 51662-1251). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51662 1251 2 Pouch Label Image

Label for PHENYTOIN SODIUM Injection, USP 50 mg/mL strength, presented as a 2 mL vial with a total of 100 mg per vial. The label includes NDC 51662-1251-2, lot number, and expiration date. It specifies intravenous or intramuscular use and manufacturer as HF Acquisition Co LLC, Mukilteo, WA.*

FDA Label Image

51662 1251 3 Rfid Label Image

This image shows a white adhesive pharmaceutical label with a Data Matrix barcode and human-readable GS1 application identifier (AI) numbers. The label includes AI (01) Global Trade Item Number, (17) expiration date, (21) serial number, and (10) batch or lot number. The text notes distribution by HF Acquisition Co., LLC, Mukilteo, WA 98275, and states "See manufacturer's package insert" and "RX ONLY." The label does not display product name, strength, or dosage form.*

FDA Label Image

51662 1251 3 Case Label Image

Label for PHENYTOIN SODIUM Injection USP 100 mg per 2 mL (50 mg/mL) in a 2 mL vial, package of 25. The label includes NDC 51662-1251-3, lot number, and expiration date, with usage instructions for intravenous or intramuscular administration. Manufactured by HF Acquisition Co LLC, DBA HealthFirst.*

FDA Label Image

Boxed Warning (Boxed Warning)

A warning text panel for Phenytoin Sodium Injection, highlighting the cardiovascular risk associated with rapid infusion. It advises that the intravenous administration rate should not exceed 50 mg per minute in adults and 3 mg/kg/min in pediatric patients, emphasizing the need for careful cardiac monitoring and possible dosage adjustments due to risks of hypotension and arrhythmias.*

FDA Label Image

Drug Inter 1 (Drug Interactions 1)

A table listing interacting agents that affect phenytoin serum levels. It categorizes drugs that may increase, decrease, or either increase or decrease phenytoin serum levels, with examples including antiepileptic drugs, azoles, antineoplastic agents, antidepressants, gastric acid reducing agents, sulfonamides, antiviral agents, and others.*

FDA Label Image

Drug Inter 2 (Drug Interactions 2)

A data table listing drugs and drug classes that interact with phenytoin sodium. It categorizes drugs whose efficacy is impaired by phenytoin and those whose levels are decreased by phenytoin, including examples such as azoles, antineoplastic agents, delavirdine, neuromuscular blocking agents, warfarin, antiepileptic drugs, antilipidemic agents, antiviral agents, and calcium channel blockers.*

FDA Label Image

Highlight Warning Box (Highlight Warning Box)

A warning text panel for Phenytoin Sodium Injection highlighting cardiovascular risks associated with rapid infusion. It advises that intravenous administration should not exceed 50 mg per minute in adults and 1 to 3 mg/kg/min in pediatric patients due to risks of hypotension and cardiac arrhythmias. The panel also emphasizes the need for careful cardiac monitoring and potential dose adjustment.*

FDA Label Image

Serialized (Serialized Label 51662 1251 1 Phenytoin Sodium 1)

Phenytoin Sodium injection vial showing a small clear glass container with a gray and brown stopper. The label includes a barcode, product identification text including the name "Phenytoin Sodium", and distribution information by HF Acquisition Co LLC, Mukilteo, WA. The vial is intended for intramuscular or intravenous use as an injectable solution at 50 mg/mL.*

FDA Label Image

Structure (Structure)

Chemical structure of Phenytoin Sodium, showing its molecular arrangement with two benzene rings and sodium ion attached to the molecular framework.*

FDA Label Image

Vial (Vial Label)

Label for Phenytoin Sodium Injection, USP, 50 mg/mL strength presented as 100 mg/2 mL in a single-dose vial. The label indicates it is for intravenous or intramuscular use only and warns against use if hazy or if precipitate is present. Manufactured by West-Ward, the label includes NDC 0641-0493-21 and spaces for lot and expiration dates.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.